CONTENTS 



Hearing held November 9, 1993 1 



Statement of: 



Brewer, Dr. Steve, Manager, Bioproducts Chemistry, Monsanto Company- 



Searle JO 



Prepared statement ^^ 



Grossman, Dr. John, Resource Development Administrator, Eastern Mu- 

 nicipal Water District, Southern California 12 



Prepared statement ;■ ^6 



Eisner, Dr. Thomas, Director, Cornell Institute for Research and Chemi- 

 cal Ecology, Cornell University 3 



Fields, Hon. Jack, a U.S. Representative from Texas, and Ranking Mmor- 



ity Member, Committee on Merchant Marine and Fisheries 19 



Forman, Elaine B., Cancer patient treated with taxol 8 



Furse, Hon. Elizabeth, a U.S. Representative from Oregon 2 



Grever, Dr. Michael, Associate Director, Developmental Therapeutics 



Program, The National Cancer Institute 5 



PT'pnjiT'pfi stfit€*iTiGnt 



McMahon, Dr. Linda, Executive Director, the Berry Botanic Garden, 



Portland, Oregon 1^ 



Prepared statement 58 



Studds, Hon. Gerry E., a U.S. Representative from Massachusetts, and 



Chairman, Subcommittee on Environment and Natural Resources 1 



Additional material supplied: 



Clemente, Constantine L. (Pfizer Inc.): Written statement in regard to 

 medicinal uses of plants and the protection affordrd to plants under the 



ESA " 62 



Grever, Dr. Michael (The National Cancer Institute): Results of testmg of 



trichosanthin by the National Cancer Institute 33 



Newpher, Richard W. (American Farm Bureau Federation): Statement 

 addressing protections provided to plants under the ESA, plus two 



attachments 6o 



Upton, Roy (American Herbalists Guild): Comments regarding medicinal 

 uses of plants and their protection under the ESA 81 



(III) 



